Lockheed Martin is cheap against its earnings, trading at 22x trailing and 18x next year's, versus the 24x aerospace and defense suppliers usually get. At 24x next year's $32.72 EPS, give or take 12%, fair value runs $690.97 to $879.42, so the stock sits 15% below where fair value starts. This is a valuation read on reported earnings and estimates only, not fundamental work. x.com 

Lockheed Martin looks like a really great opportunity in defense, with orders outpacing deliveries at a reasonable valuation. Its backlog is a record $230B, almost 3x expected 2026 revenue, after $65B of new Q2 orders. Q2 sales grew 11% to $20.1B, and management raised free cash flow guidance to over $7B for 2026. It trades at about 18-19x 2026 earnings, reasonable for a sector leader; the next few weeks are about finding an entry point. x.com 

Lockheed Martin is the straightforward defense buy, with a 3.2x book-to-bill. The stock fell last quarter because capex rose to meet very high demand, a dumb reaction. @kaizen_cap adds that money from awarded contracts flows over multiple years, so peak awards and revenue recognition may come in 2027-2028 even with a flat budget. x.com  x.com 

Lockheed Martin, now down for the year, is a buy for the long-term portfolio because defense is always needed. x.com 

Lockheed Martin's $4.7 billion Patriot interceptor contract shows a defense supercycle whose backlog Wall Street has not fully priced. Patriot is the backbone of US and allied air defense, countries are asking how fast they can get one, and more contracts are behind this one. Defense budgets are accelerating globally with bipartisan political will, and governments rarely cut them once they start; the money also flows down to suppliers. x.com  x.com 

Curtiss-Wright, an aerospace, defense and commercial nuclear supplier, is expensive against its earnings. At $545.79 it trades at 38 times earnings and 32 times next year's, versus the roughly 24 times aerospace and defense suppliers usually get. Fair value is $361.97 to $460.69, 24 times next year's $17.14 per share give or take 12%, putting the stock 18% above the high end; it is expensive above $582.72. This is a valuation-only view based on reported earnings and estimates. x.com